Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

CSE:RVV - Post by User

Revive Therapeutics Ltd.

<< Previous

Bullboard Posts

Next >>

Post by Bentley2000on Aug 18, 2021 3:06pm

166 Views

Post# 33724702

NEWS

Market News & Research Alert

News for RVV

Alert Sent 2021-08-18 02:11:27 PM ET

Delivery preference: Immediate delivery

Proactive news headlines including Globex Data, Revive Therapeutics, Mirasol Resources and Mydecine Innovations

2021-08-18 02:10:14 PM ET (GlobeNewswire)

Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies
About Proactive »¿
With six offices on three continents and a team of experienced business journalists and broadcasters, Proactive works with innovative growth companies quoted on the world's major stock exchanges, helping executives engage intelligently with investors.
Proactive's platform delivers the right message to the right audience, digitally and in real time, leveraging a range of media, investment research, digital investor targeting and website development services to support over 1,000 fast-growing companies globally.
Proactive's network reaches over 12 million engaged private, professional and institutional investors looking for opportunities.
? Our written and video content is published on Proactive sites that collectively attract up to 10 million views per month.
? We syndicate our content to hundreds of mainstream and specialist news sites that expand our reach into networks that can be difficult for press releases to penetrate.
? We custom build corporate websites from the ground up, empowering clients and their brands with a modern online presence and the latest insight on effective SEO strategy
? Our news coverage ranks high on the world's most popular search platforms, and we can further amplify online presence and outreach with sophisticated digital investor targeting.
? We help the world understand what makes companies stand out from the crowd with in-depth investment research from a team of experienced analysts.
For more information on how Proactive can help you make a difference, email us at action@paidpromotionalmessages.com
<img src="https://ml-eu.globenewswire.com/media/ODM0MTAwMjUtNjkzYy00ODNmLWE0YmItMDFmMGEzZTgzMzUxLTExNjg1MjE=/tiny/Proactive-Investors.png" referrerpolicy="no-referrer-when-downgrade" /><p>https://ml-eu.globenewswire.com/media/24b86192-1fcd-41fd-bf5d-5238057ae09b/small/pro-logo-l-colour-jpg.jpg
https://ml-eu.globenewswire.com/media/24b86192-1fcd-41fd-bf5d-5238057ae09b/small/pro-logo-l-colour-jpg.jpg

COMTEX_391796519/2010/2021-08-18T14:10:14

K=Thousands, M=Millions, B=Billions, TTM=Trailing 12 Month, MRQ=Most Recent Quarter, FYR=Fiscal Year End, NM=Not Meaningful, NA=Not Available

GAAP = Generally Accepted Accounting Principles used in Financial Statements issued by the company, Non-GAAP = Adjusted Operating Earnings or Revenue used in comparison to Analyst Estimates.Adjustments are typically one-time gains or losses.

Quotes, News, and Fundamentals provided by